..but the big one for poh is..
Our pipeline depth is vast and many of the applications are non-therapeutic meaning a fast route to market. However our therapeutic applications through transdermal applications will become Gold Standard in companion animal and production animal post-operative pain relief.
IAH will be a huge winner...
with TPM..it's our science folks, and we will reap the benefits also
iah website, page-7
-
- There are more pages in this discussion • 95 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.001(20.0%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $2.635K | 1.045M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 57 | 93538418 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 60456317 | 21 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| AVE (ASX) Chart |